(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TEZRULY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

TEZRULY

ST13

US500000097808542

Class

5

Filing

97808542

Registration

8087742

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

12/31/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

02/23/2023

Registration date

12/30/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/30/2025

Last transaction

12/31/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/23/2025

First use in commerce

04/29/2025

Drawing code

4

Owner type

03

Owner location

Baudette, MN

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ANI Pharmaceuticals, Inc.

Representatives

Aydin H. Harston ROTHWELL, FIGG, ERNST & MANBECK, PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of oncological and cardiovascular diseaseshypertensionrenal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/30/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/30/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/09/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/09/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/07/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/07/2025

IUAF

USE AMENDMENT FILED

06/11/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/11/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2025

EX3G

SOU EXTENSION 3 GRANTED

12/05/2024

EXT3

SOU EXTENSION 3 FILED

12/05/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/05/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/13/2024

EX2G

SOU EXTENSION 2 GRANTED

06/05/2024

EXT2

SOU EXTENSION 2 FILED

06/05/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/05/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/13/2023

EX1G

SOU EXTENSION 1 GRANTED

12/11/2023

EXT1

SOU EXTENSION 1 FILED

12/11/2023

EEXT

SOU TEAS EXTENSION RECEIVED

12/11/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/13/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/18/2023

PUBO

PUBLISHED FOR OPPOSITION

04/18/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/16/2023

DOCK

ASSIGNED TO EXAMINER

03/16/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/14/2023

NWAP

NEW APPLICATION ENTERED

02/27/2023

Continuous trademark protection

Get notified about every new filing that threatens TEZRULY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.